Wealthfront Advisers LLC purchased a new stake in Tenet Healthcare Co. (NYSE:THC - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 547,088 shares of the company's stock, valued at approximately $69,059,000. Wealthfront Advisers LLC owned approximately 0.58% of Tenet Healthcare as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. New Wave Wealth Advisors LLC purchased a new position in Tenet Healthcare during the 4th quarter valued at about $343,000. Swedbank AB grew its holdings in shares of Tenet Healthcare by 100.0% during the fourth quarter. Swedbank AB now owns 40,000 shares of the company's stock worth $5,049,000 after buying an additional 20,000 shares in the last quarter. Signet Financial Management LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth about $1,526,000. China Universal Asset Management Co. Ltd. purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth about $410,000. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth about $5,892,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.
Tenet Healthcare Price Performance
Shares of NYSE THC opened at $126.21 on Tuesday. Tenet Healthcare Co. has a twelve month low of $90.03 and a twelve month high of $171.20. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The company has a market capitalization of $12.01 billion, a price-to-earnings ratio of 3.92, a PEG ratio of 1.02 and a beta of 2.06. The firm has a 50-day moving average of $132.68 and a two-hundred day moving average of $145.65.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. As a group, analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on the stock. Raymond James downgraded shares of Tenet Healthcare from a "strong-buy" rating to an "outperform" rating and set a $195.00 price target for the company. in a report on Friday, November 22nd. KeyCorp decreased their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. Barclays reduced their price target on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a research report on Thursday, February 13th. Truist Financial reduced their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $177.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $163.88.
View Our Latest Report on Tenet Healthcare
Tenet Healthcare Profile
(
Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Read More
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.